StockNews.AI
ILMN
StockNews.AI
131 days

Illumina to Announce First Quarter 2025 Financial Results on Thursday, May 8, 2025

1. Illumina to announce Q1 2025 results on May 8, 2025. 2. CEO and CFO will discuss financial results in a conference call. 3. Live webcast and replay will be available on Illumina’s website.

Earnings
+4.94%Current Return
VS
+1.76%S&P 500
$71.2604/10 04:07 PM EDTEvent Start
$74.7804/11 10:29 PM EDTLatest Updated
4m saved
Insight
Article

FAQ

Why Neutral?

The announcement pertains to scheduled earnings without significant new information potentially driving the price.

How important is it?

Earnings calls can impact stock prices based on results but are routine events.

Why Short Term?

Market responses to quarterly earnings are typically immediate but short-lived.

Related Companies

GRMNPACB
, /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) announced today that it will issue results for the first quarter 2025 following the close of market on Thursday, May 8, 2025.  On the same day, at 1:30 pm Pacific Time (4:30 pm Eastern Time) Jacob Thaysen, PhD, Chief Executive Officer, and Ankur Dhingra, Chief Financial Officer, will host a conference call with analysts, investors, and other interested parties to discuss financial and operating results.  Conference Call Details The conference call will begin at 1:30 pm Pacific Time (4:30 pm Eastern Time) on Thursday, May 8, 2025. Interested parties may access the live webcast via the Investor Info section of Illumina's website or directly through the following link - https://illumina-earnings-call-q1-2025.open-exchange.net/registration. To ensure timely connection, please join at least ten minutes before the scheduled start of the call. A replay of the conference call will be posted on Illumina's website after the event and will be available for at least 30 days following. About Illumina Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit www.illumina.com and connect with us on X (Twitter), Facebook, LinkedIn, Instagram, TikTok, and YouTube. Investors:Brian Blanchett+1.858.291.6421[email protected] Media:Bonny Fowler+1.740.641.5579[email protected] SOURCE Illumina, Inc. WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News